Cargando…

Complement receptor 1 polymorphisms associated with resistance to severe malaria in Kenya

BACKGROUND: It has been hypothesized that the African alleles Sl2 and McC(b )of the Swain-Langley (Sl) and McCoy (McC) blood group antigens of the complement receptor 1 (CR1) may confer a survival advantage in the setting of Plasmodium falciparum malaria, but this has not been demonstrated. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Thathy, Vandana, Moulds, JoAnn M, Guyah, Bernard, Otieno, Walter, Stoute, José A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1308855/
https://www.ncbi.nlm.nih.gov/pubmed/16277654
http://dx.doi.org/10.1186/1475-2875-4-54
_version_ 1782126295631527936
author Thathy, Vandana
Moulds, JoAnn M
Guyah, Bernard
Otieno, Walter
Stoute, José A
author_facet Thathy, Vandana
Moulds, JoAnn M
Guyah, Bernard
Otieno, Walter
Stoute, José A
author_sort Thathy, Vandana
collection PubMed
description BACKGROUND: It has been hypothesized that the African alleles Sl2 and McC(b )of the Swain-Langley (Sl) and McCoy (McC) blood group antigens of the complement receptor 1 (CR1) may confer a survival advantage in the setting of Plasmodium falciparum malaria, but this has not been demonstrated. METHODS: To test this hypothesis, children in western Kenya with severe malaria-associated anaemia or cerebral malaria were matched to symptomatic uncomplicated malaria controls by age and gender. Swain-Langley and McCoy blood group alleles were determined by restriction fragment length polymorphism and conditional logistic regression was carried out. RESULTS: No significant association was found between the African alleles and severe malaria-associated anaemia. However, children with Sl2/2 genotype were less likely to have cerebral malaria (OR = 0.17, 95% CI 0.04 to 0.72, P = 0.02) than children with Sl1/1. In particular, individuals with Sl2/2 McC(a/b )genotype were less likely to have cerebral malaria (OR = 0.18, 95% CI 0.04 to 0.77, P = 0.02) than individuals with Sl1/1 McC(a/a). CONCLUSION: These results support the hypothesis that the Sl2 allele and, possibly, the McC(b )allele evolved in the context of malaria transmission and that in certain combinations probably confer a survival advantage on these populations.
format Text
id pubmed-1308855
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-13088552005-12-08 Complement receptor 1 polymorphisms associated with resistance to severe malaria in Kenya Thathy, Vandana Moulds, JoAnn M Guyah, Bernard Otieno, Walter Stoute, José A Malar J Research BACKGROUND: It has been hypothesized that the African alleles Sl2 and McC(b )of the Swain-Langley (Sl) and McCoy (McC) blood group antigens of the complement receptor 1 (CR1) may confer a survival advantage in the setting of Plasmodium falciparum malaria, but this has not been demonstrated. METHODS: To test this hypothesis, children in western Kenya with severe malaria-associated anaemia or cerebral malaria were matched to symptomatic uncomplicated malaria controls by age and gender. Swain-Langley and McCoy blood group alleles were determined by restriction fragment length polymorphism and conditional logistic regression was carried out. RESULTS: No significant association was found between the African alleles and severe malaria-associated anaemia. However, children with Sl2/2 genotype were less likely to have cerebral malaria (OR = 0.17, 95% CI 0.04 to 0.72, P = 0.02) than children with Sl1/1. In particular, individuals with Sl2/2 McC(a/b )genotype were less likely to have cerebral malaria (OR = 0.18, 95% CI 0.04 to 0.77, P = 0.02) than individuals with Sl1/1 McC(a/a). CONCLUSION: These results support the hypothesis that the Sl2 allele and, possibly, the McC(b )allele evolved in the context of malaria transmission and that in certain combinations probably confer a survival advantage on these populations. BioMed Central 2005-11-08 /pmc/articles/PMC1308855/ /pubmed/16277654 http://dx.doi.org/10.1186/1475-2875-4-54 Text en Copyright © 2005 Thathy et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Thathy, Vandana
Moulds, JoAnn M
Guyah, Bernard
Otieno, Walter
Stoute, José A
Complement receptor 1 polymorphisms associated with resistance to severe malaria in Kenya
title Complement receptor 1 polymorphisms associated with resistance to severe malaria in Kenya
title_full Complement receptor 1 polymorphisms associated with resistance to severe malaria in Kenya
title_fullStr Complement receptor 1 polymorphisms associated with resistance to severe malaria in Kenya
title_full_unstemmed Complement receptor 1 polymorphisms associated with resistance to severe malaria in Kenya
title_short Complement receptor 1 polymorphisms associated with resistance to severe malaria in Kenya
title_sort complement receptor 1 polymorphisms associated with resistance to severe malaria in kenya
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1308855/
https://www.ncbi.nlm.nih.gov/pubmed/16277654
http://dx.doi.org/10.1186/1475-2875-4-54
work_keys_str_mv AT thathyvandana complementreceptor1polymorphismsassociatedwithresistancetoseveremalariainkenya
AT mouldsjoannm complementreceptor1polymorphismsassociatedwithresistancetoseveremalariainkenya
AT guyahbernard complementreceptor1polymorphismsassociatedwithresistancetoseveremalariainkenya
AT otienowalter complementreceptor1polymorphismsassociatedwithresistancetoseveremalariainkenya
AT stoutejosea complementreceptor1polymorphismsassociatedwithresistancetoseveremalariainkenya